EvoRadar
Pricing
AI BrainIdeasDice
2078 ideas0 HOT466 WARM1612 COLD
© 2026 Kisum GmbH|ImpressumDatenschutzAGB|GitHub
EvoRadar — AI-Discovered Startup Opportunitiesevoradar.ai
© 2026 Kisum GmbHevoradar.ai · Generated by EvoRadar
← BackWatch AI Discovery

Patient ACA External Review Submission Builder

COLD✧ v8healthcare / consumer legal rightsNorth America16 Mar 2026

One-Liner

A consumer tool generating ready-to-file ACA Section 2719 external review submissions for patients whose insurance claims have been denied.

AI Thinking Process

Impossibility Negation engine fired: 'You can't generate plain-language patient appeals for ACA External Review at scale' — was true two years ago. Now possible with large-context AI reading denial letters, 100-page coverage documents, and relevant medical guidelines.

Patient ACA External Review Submission Builder: consumer tool reading denial letter + plan coverage doc + medical guidelines, drafting IRO submission packet. ACA Section 2719 gives federal right to binding external review. 40% historical reversal rate. Per-event pricing $99-249 + success fee.

WHO: US patient or parent with >$500 denied insurance claim. CURRENT: accept denial (~80% case rate) or hire patient advocate at $300-500/hour. WHY-SURPRISED: federal right exists, IRO process documented, success rates ~40%, but no consumer self-serve tool prepares the submission. G053 pattern confirmed.

Memory scan: Brella, Health Advocate (broker-paid), Resolve (medical billing, not appeals), Solace ($14M, advocates). No consumer AI ACA External Review tool recalled. G016 memory blindness flag applied.

Survived Pass 1 at 45% conviction. Biggest worry: Solace or another patient-advocate marketplace launches self-serve AI external review feature within 18 months.

Counterforce Health: free AI appeal generator, NIH + UPenn funded, 70% success rate, explicit external review panel support, featured in CBS Philadelphia, NBC News, Axios, US News. Claimable Inc.: $50/appeal, 80% success rate, customized appeal letters with clinical research. Solace: human advocates including explicit IRO submission support. Three separate offerings cover free, transactional, and premium tiers.

KILLED IN DEEPENING: Counterforce Health (free, NIH-funded, national media) and Claimable Inc. ($50, 80% success) occupy exactly the proposed product and pricing spaces. The 'empty consumer-regulatory category' thesis was refuted. No brand-establishment window remains.

Kill Reason

Counterforce Health (NIH and University of Pennsylvania funded, 70% success rate, free to consumers, national media coverage) and Claimable Inc. ($50 per appeal, 80% success rate) already occupy the exact product and pricing spaces proposed. Solace Health provides the premium human-advocate alternative. The 'empty category' thesis was refuted by a 30-second web search.

Risk Analysis

Risk analysis available for latest engine ideas.

What do you think?

Related ideas you can explore free:

COLDPatient No Surprises Act IDR Bill Dispute Builder

killed: Historical duplicate of 'No Surprises Act Consumer Medical Bill Dispute Platform' from session 20260413-1538-crossdomain (4 days prior). Same federal IDR regulation, same consumer patient buyer, same core dispute-workflow value proposition.

COLDMulti-Chip AI Orchestration Platform

killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.

COLDGPU Compute Brokerage

killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.